Complementing the Standard Multicomponent Treatment for Smokers With Denicotinized Cigarettes: A Randomized Trial

Area of Science:

• Addiction Medicine
• Behavioral Science
• Pharmacology

Background:

• Standard smoking cessation treatments (STs) often combine pharmacotherapy and behavioral support.
• These treatments may not fully address the sensory and behavioral aspects of smoking.
• Denicotinized cigarettes (DNCs) offer sensory stimuli without nicotine, potentially aiding cessation.

Purpose of the Study:

• To investigate the efficacy of adding DNCs to standard smoking cessation treatments.
• To determine if DNCs can alleviate urges to smoke and withdrawal symptoms.
• To assess the impact of DNCs on smoking abstinence rates.

Main Methods:

• Two hundred smokers received standard treatment (pharmacotherapy and behavioral support).
• Participants were randomized to receive either DNCs (used ad libitum for 2 weeks) or standard treatment alone.
• Smoking abstinence was assessed at 1, 4, and 12 weeks post-quit.

Main Results:

• DNC users reported significantly lower urge-to-smoke frequency in the first week of abstinence.
• Smoking abstinence rates were significantly higher in the DNC group at 1 and 4 weeks compared to standard treatment alone.
• No significant differences in withdrawal scores or 12-week abstinence rates were observed between groups.

Conclusions:

• Adding DNCs to standard smoking cessation treatment shows potential for early-stage quit attempts.
• DNCs may help manage smoking urges and improve short-term abstinence.
• Further research is required to optimize the utilization of DNCs in cessation programs.